BHST · Bioharvest Sciences Inc. · Financials
$1.68
-0.08 (-4.55%)
At close · Oct 29
Return incl. dividend (before tax)
Q2 2026 earnings call transcript
Market Cap
$39.90M
Shares
22.67M
Volume · Oct 29
20.43K
Avg daily vol (3M)
39.69K
Income-statement, balance-sheet and cash-flow figures from SEC filings, plus a debt profile anchored in the latest 10-K and updated by each 10-Q and debt exhibit.
Revenue
$34.51M
+37%
FY2025
Net Income
-$11.14M
+13.8%
FY2025
Gross Margin
59.34%
+4pp
FY2025
Operating Margin
-16.16%
+11.6pp
FY2025
Operating Cash Flow
-$7.23M
-8.1%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | FY2026 (G) | FY2025 | FY2024 | FY2023 |
|---|---|---|---|---|
| $37M – $40M | $34.51M | $25.19M | $12.67M | |
| — | $14.03M | $11.25M | $7.04M | |
| — | $20.48M | $13.94M | $5.63M | |
| — | 59.34% | 55.35% | 44.45% | |
| — | $5.31M | $4.8M | $3.37M | |
| — | $4.93M | $4.4M | $4.48M | |
| — | $1.62M | $1.25M | $840K | |
| — | $26.05M | $20.93M | $15.6M | |
| — | -$5.58M | -$6.99M | -$9.97M | |
| — | -16.16% | -27.75% | -78.65% | |
| — | -$3.95M | -$5.74M | -$9.13M | |
| — | -$11.06M | -$12.91M | -$12.56M | |
| — | -$76K | -$8000 | $0 | |
| — | -$11.14M | -$12.91M | -$12.56M | |
| — | -32.27% | -51.27% | -99.15% | |
| USD/shares | — | -$0.60 | -$0.80 | -$0.93 |
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
(G): the company's own guidance — a (G) column is a guided period not yet reported; a G marker shows how the reported figure landed against the guided range. Non-GAAP-basis guidance (*) is shown as stated and never judged against GAAP actuals.
Debt Profile
Reported borrowing balances, repayment dates and agreement terms, with links to the underlying filings.
Reported debt balances
Each amount keeps its reported scope. Related balance-sheet measures appear under the borrowing they describe.
| Reported balance | As of | Amount | Source |
|---|---|---|---|
| Lease liabilities | 2025-12-31 | USD 1,405,000 | 40-F filed 2026-03-31 |
| Noncurrent finance lease liabilities | 2025-12-31 | USD 10,130,000 | 40-F filed 2026-03-31 |
| Short-term borrowings | 2025-12-31 | USD 149,000 | 40-F filed 2026-03-31 |
Instrument and agreement coverage is incomplete. Additional filings are awaiting review.
Covenants
Covenant terms have not yet been verified for this profile.
The balance figures do not establish whether covenants apply or whether the company complies with them.
Loans, facilities and notes
The instrument breakdown is not yet verified. Read the debt note in the linked report for borrowing terms and maturity conditions.